-
BofA Securities Downgrades Fresenius Medical Care (FMS) to Underperform
-
BofA Securities Downgrades Fresenius Medical Care AG & Co KGaA (FME:GR) (FMS) to Underperform
-
Fresenius Medical Care (FMS) call put ratio 20 calls to 1 put with a focus on April 30 calls
-
Fresenius Medical Care invests €312 million in Interwell Health unit
-
UBS Downgrades Fresenius Medical Care AG & Co KGaA (FME:GR) (FMS) to Sell
-
Generation Income Properties Secures Early Best Buy Lease Extension, Highlighting Tenant Commitment at an Increased Rent; Provides Update on Chicago Property Agreement
-
Generation Income Properties Announces Q2 2025 Financial and Operating Results
-
Fresenius Medical Care (FMS) Tops Q2 EPS by 41c; offers outlook
-
Goldman's Monthly Update to European Conviction List
-
Fresenius Medical Care AG & Co KGaA (FME:GR) (FMS) PT Raised to EUR56 at BofA Securities
-
Truist Securities Reiterates Hold Rating on Fresenius Medical Care (FMS)
-
Bernstein: 'We See Fresenius Medical Care (FMS) As a Tactical Buy After the Sell-Off'; PT Raised
-
Fresenius Medical Care (FMS) Annual General Meeting: Strong Performance Against Its Strategic Plan Results in Highest Dividend per Share in Its History
-
Fresenius Medical Care (FMS) Tops Q1 EPS by 7c, provides outlook
-
Fresenius Medical Care (FMS) Misses Q4 EPS by 26c; offers outlook
-
HSBC Upgrades Fresenius Medical Care AG & Co KGaA (FME:GR) (FMS) to Buy
-
BofA Securities Upgrades Fresenius Medical Care AG & Co. KGaA (FME:GR) (FMS) to Neutral
-
BofA Securities Upgrades Fresenius Medical Care (FMS) to Neutral
-
Fresenius Medical Care (FMS) Tops Q3 EPS by 35c
-
Fresenius Medical Care (FMS) Tops Q2 EPS by 33c

